Shirley Ryan AbilityLab
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Shirley Ryan AbilityLab sits in the top decile of US sponsors by registered trial count (#204 of 15,742 sponsors by registered trial count).
Shirley Ryan AbilityLab: 138 sponsored US clinical trials, 36 recruiting.
Shirley Ryan AbilityLab sponsors 138 registered US clinical trials on ClinicalTrials.gov, 36 of them currently recruiting, and 69 completed. 5 of these trials are in Phase 3-4 (later-stage) and 11 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 24 trials.
Top-decile sponsor footprint
Shirley Ryan AbilityLab ranks in the top decile of sponsors by registered trial count (#204 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
69 of 72 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (95.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
138 total, page 1 of 3
tSCS and 5-Azacitidine for Enhanced Motor Outcomes in Cerebral Palsy
NCT07433023
Smart AFO and 5-Azacitidine to Enhance Mobility in Children With Cerebral Palsy
NCT07434492
Clinical Outcome Assessment for AT & BCI
NCT07407725
Enhancing Rehabilitation Participation in Patients With SCI/D Using Motivational Interviewing
NCT07364773
Transcutaneous Electrical Stimulation for Stroke Patients
NCT06950593
Evaluation of the Safety and Efficacy of a Full-Body Electrostimulation Garment for Individuals With Neurological and Neuromuscular Conditions That Cause Spasticity, Hyperreflexia, and Pain
NCT07132775
WIM Exosuit Wearable Soft Robot for Enhancing Walking Activity
NCT07061691
Wearable Sensors to Detect Atypical Muscle Activation in Young Infants
NCT06970522
Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS
NCT06390930
Double Dose 4-AP on Functional Recovery After Spinal Cord Injury
NCT06853015
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
NCT06655636
R01.Aim 2.Study 1: IsoReach
NCT06656754
Mindfulness, Exercise, and Nutrition To Optimize Resilience (MENTOR)
NCT06560619
Noninvasive Vagal Nerve Stimulation and Cognitive Rehabilitation
NCT06589362
Development of Camera Based Gait Quality Measure for Persons With Multiple Sclerosis
NCT06516458
Intermittent Hypoxia in Persons With Multiple Sclerosis
NCT06276634
Characterization and Clinical Trial of a Variable Friction Shoe
NCT06234124
Remote Therapeutic Monitoring Exercise Tracking
NCT06306768
Improving Attention in Individuals With Long COVID-19
NCT06503874
Nomad P-KAFO Study
NCT05644522
Powered Prosthesis for Use With TF Osseointegration Recipients
NCT06160882
Understanding How Powered Componentry Impacts K2-Level Transfemoral Amputee Gait
NCT06433648
Multimodal Haptic Feedback for Plantar Sensory Substitution
NCT06232512
Error-enhanced Learning & Recovery in 2 & 3 Dimensions
NCT05180786
Neurostimulation for Respiratory Function After Spinal Cord Injury
NCT05756894
Improving Adherence to Spinal Cord Injury Exercise Guidelines Using Smartphone Technology and E-coaching
NCT05424172
Neuromuscular Mechanisms of Specific Trunk Interventions in Children With CP
NCT05805410
Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit
NCT05568264
C-STAR Movement Database
NCT05471375
Locomotor Function Following Transcutaneous Electrical Spinal Cord Stimulation in Individuals With Hemiplegic Stroke
NCT05167786
Human-like Robotic Controllers for Enhanced Motor Learning
NCT04578665
Sensory-specific Peripheral Stimulation for Tremor Management
NCT04501133
Intuitive Control of a Hybrid Prosthetic Leg During Ambulation
NCT04038151
Improve Dynamic Lateral Balance of Humans With SCI
NCT02991248
Inpatient Stroke Recovery Using Sensors
NCT04219670
Constraint Induced Movement Therapy for Walking in Individuals Post Stroke
NCT03264261
Transcutaneous Spinal Cord Stimulation in Healthy Adults
NCT06116838
Pilot Remote Therapeutic Monitoring in Cancer Patients
NCT07007039
Assessing Upper Extremity Function in Chronic Stroke Survivors Through Acute Intermittent Hypoxia
NCT07113457
Impact of Sensory Electrical Stimulation on Sensation and Tremor
NCT06428526
The Synergistic Effects of AIH and FES in Persons With MS
NCT06413602
Effects of Vibration on Motor Function of Survivors of Chronic Stroke
NCT06663501
Muscle Coordination-Based Feedback for Stroke Rehabilitation
NCT06099444
Development and Usability of an Adjustable Prosthesis for Aquatic Therapy
NCT06259695
Impact of Different Exercise Programs on Knee OA
NCT05844124
Arm and Leg Cycling for Accelerated Recovery From SCI
NCT05619146
Validation of a Spasticity Measurement Tool
NCT05374174
Safety and Feasibility of ExoNET
NCT05180812
Tracking Neural Synergies After Stroke.
NCT04805866
Real-time Neuromuscular Control of Exoskeletons
NCT04661891
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 8 |
| Phase 2 | 3 |
| Phase 3 | 1 |
| Phase 4 | 4 |
What is open in the Shirley Ryan AbilityLab pipeline
36 recruiting of 138 indexed (26% open); 69 completed (50%).
Phase mix: 5 late (III/IV) vs 11 early (I/II) (early-phase heavy).
Top condition: Stroke (24 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Shirley Ryan AbilityLab: open-pipeline peers nationwide
Peers matched on 138 registered trials and 26% open enrollment, not the therapeutic-area sidebar.
Shirley Ryan AbilityLab sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 138 trials (± recruiting share)
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · 138 trials · 3% recruiting
- Barbara Ann Karmanos Cancer Institute · 139 trials · 12% recruiting
- Centers for Disease Control and Prevention · 139 trials · 2% recruiting
- Mclean Hospital · 140 trials · 19% recruiting
Sponsors near 26% open enrollment (± trial volume)
- University Health Network, Toronto · 26% recruiting · 23 trials
- Syracuse University · 26% recruiting · 31 trials
- Rutgers, The State University of New Jersey · 26% recruiting · 413 trials
- Hackensack Meridian Health · 26% recruiting · 90 trials
Related
What to do with this Shirley Ryan AbilityLab page
138 registered trials is a research-attention snapshot, not an endorsement of Shirley Ryan AbilityLab or any single study.
- 36 of Shirley Ryan AbilityLab's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition Shirley Ryan AbilityLab studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Shirley Ryan AbilityLab pipeline card: 138 registered trials from official public datasets.Report a data error.